The stock of Anebulo Pharmaceuticals Inc (ANEB) has gone up by 6.22% for the week, with a 11.00% rise in the past month and a 9.90% rise in the past quarter. The volatility ratio for the week is 25.82%, and the volatility levels for the past 30 days are 10.47% for ANEB. The simple moving average for the past 20 days is 10.11% for ANEB’s stock, with a -7.71% simple moving average for the past 200 days.
Is It Worth Investing in Anebulo Pharmaceuticals Inc (NASDAQ: ANEB) Right Now?
Additionally, the 36-month beta value for ANEB is -1.01. There are mixed opinions on the stock, with 2 analysts rating it as a “buy,” 1 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ANEB is 9.28M and currently, short sellers hold a 0.15% ratio of that float. The average trading volume of ANEB on September 24, 2024 was 7.99K shares.
ANEB) stock’s latest price update
The stock of Anebulo Pharmaceuticals Inc (NASDAQ: ANEB) has decreased by -27.92 when compared to last closing price of 3.08.Despite this, the company has seen a gain of 6.22% in its stock price over the last five trading days. businesswire.com reported 2024-05-15 that BOSTON–(BUSINESS WIRE)–Galehead Development, LLC (“Galehead”) and Rivian Automotive, LLC (“Rivian”) have entered into an agreement to collaborate on the development of renewable energy resources tailored to Rivian’s locational and environmental priorities. Galehead will develop solar projects with specific consideration for Rivian’s “3C” Framework. The 3C Framework is a progressive procurement standard that commits Rivian to sourcing renewable energy from projects that have a measurable posit.
ANEB Trading at 3.99% from the 50-Day Moving Average
After a stumble in the market that brought ANEB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -38.50% of loss for the given period.
Volatility was left at 10.47%, however, over the last 30 days, the volatility rate increased by 25.82%, as shares surge +15.50% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -10.84% lower at present.
During the last 5 trading sessions, ANEB rose by +6.22%, which changed the moving average for the period of 200-days by +2.78% in comparison to the 20-day moving average, which settled at $2.03. In addition, Anebulo Pharmaceuticals Inc saw -8.26% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ANEB
The total capital return value is set at -1.9. Equity return is now at value -104.28, with -91.51 for asset returns.
Currently, EBITDA for the company is -11.78 million with net debt to EBITDA at 0.54. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.32.
Conclusion
In conclusion, Anebulo Pharmaceuticals Inc (ANEB) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
